About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline



24 Loy. L.A. Ent. L. Rev. [i] (2004)

handle is hein.journals/laent24 and id is 1 raw text is: LOYOLA
OF LOS ANGELES
ENTERTAINMENT
LAW REVIEW

VOLUME TWENTY-FOUR                    2004                            NUMBER 1
TABLE OF CONTENTS
SYMPOSIA
2003 Stanford Law & Technology Association Conference:
Ideas Without Boundaries: Creating and Protecting
Intellectual Property in the International Arena
INTERNATIONAL CHALLENGES FOR THE PHARMACEUTICALIBIOTECH INDUSTRIES IN
THE  21ST  C ENTURY  ................................................................................ .. .........1
The   pharmaceutical and  biotech  industries  are  becoming  increasingly
reliant on each other. Drug companies are using the research tools and
products developed by biotech companies to develop the new blockbuster
drugs of tomorrow. Biotech, in turn, is becoming dependent on financing
from  the  pharmaceutical industry  to  support its costly research  and
development programs. Today, globalization poses new   legal, economic,
social  and   political  challenges  for  these  interlinked  industries,
including  how  to  balance  global intellectual property  protection  with
the  need  to   bring  essential  drugs  to  impoverished  nations  at  a
reasonable  cost and  the  international debate  over what biotechnology
innovations should be patentable.
KEYNOTE: THE INTERNATIONAL INFORMATION SOCIETY
by  Law rence  Lessig  .......................................................................................  33
For the first hundred years in the United States' history, we protected
no foreign copyrights at all. We were, in the modem parlance, born a
pirate  nation. In  the  context of patents, we   have  always  had  a
tradition  that respects the  local reach  of patent protection. But at
this moment we are in      a process of reforming   that tradition. This
tradition that has taught us the importance of a balanced system    of
protection, especially in the context of things like drug patents, has